Critical appraisal on mitochondrial dysfunction in Alzheimer's disease

Faizan Ahmad1, Punya Sachdeva2

  • 1Department of Medical Elementology and Toxicology Jamia Hamdard University Delhi India.

Insights

Alzheimer's disease (AD) involves mitochondrial dysfunction, impacting cognitive decline. Understanding these mechanisms offers new therapeutic targets for this progressive neurodegenerative disorder.

Area of Science:

  • Neurodegenerative Diseases
  • Mitochondrial Biology
  • Alzheimer's Disease Pathogenesis

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing cognitive impairment.
  • AD is characterized by amyloid plaques and tau proteins.
  • Mitochondrial dysfunction is increasingly recognized as a key factor in AD.

Purpose of the Study:

  • To review mechanisms of mitochondrial dysfunction in Alzheimer's disease.
  • To explore the role of mitochondria in AD pathogenesis.
  • To identify potential therapeutic targets for AD based on mitochondrial pathways.

Main Methods:

  • Literature review of studies on Alzheimer's disease and mitochondrial function.
  • Analysis of mechanisms linking mitochondrial disruption to AD hallmarks.
  • Synthesis of current understanding of mitochondrial pathogenesis in AD.

Main Results:

  • Mitochondrial disruption leads to mitochondrial DNA (mtDNA) dysfunction.
  • Altered calcium (Ca2+) homeostasis is linked to mitochondrial dysfunction in AD.
  • Dysfunctional mitochondria contribute to copper and immune cell issues in AD.

Conclusions:

  • Mitochondrial dysfunction is central to Alzheimer's disease pathogenesis.
  • Understanding these pathways is crucial for developing novel AD therapies.
  • Targeting mitochondrial dysfunction may offer a new era for AD treatment.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
602
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.1K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
238